Life sciences

#Biopharmaceutical #Biotechnology #Drug development #Drug discovery #Life sciences

Evotec collaborates with Bristol Myers Squibb to advance therapeutics

Evotec has launched beLAB2122, a US$20 million BRIDGE (Biomedical Research, Innovation & Development Generation Efficiency) collaboration with Bristol-Myers Squibb. beLAB2122 brings together academic institutions from the Rhine-Main-Neckar region of Germany with the goal of efficiently advancing first-in-class therapeutic options across all therapeutic areas and formats into investable drug discovery and… Read More

#News

#Biologics / Biotechnology #Biopharmaceutical #Drug development #Drug discovery #Life sciences

Investment helps establish animal alternative skin testing technology

A near-£1 million investment will help University of Dundee spinout company Ten Bio to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals. The investment will enable the company to progress its mission to transform the testing of new… Read More

#News

#Cancer #Cancer research #Institute of Cancer Research #Life sciences

Work on new Innovation Gateway at The London Cancer Hub begins

The establishment of Innovation Gateway, a high-quality incubator space for life-science companies at The London Cancer Hub in Sutton, is underway. This is a significant step in realising the aims of The London Cancer Hub, a partnership between the London Borough of Sutton and The Institute of Cancer Research, that… Read More

#News

#Database #Drug development #Drug discovery #Laboratory data #Life sciences

Genemod launches platform to improve lab automation

Genemod is now offering free and paid plans for life science labs worldwide for its cloud-based platform. This is focused on inventory management and lab notebook solutions, enabling collaboration and data sharing between teammates. Genemod helps reduce back and forth time spent through traditional data entry methods, as well as… Read More

#News

#Covid-19 #Drug development #Drug discovery #Immunology / Virology & Vaccines #Life sciences #Narrated podcasts

Vaccine innovation in the age of Covid-19

This is the latest episode of the free DDW podcast, titled Vaccine innovation in the age of Covid-19. It covers two narrated articles written for DDW and read aloud by Megan Thomas. These articles are titled: “Vaccine innovation in the age of Covid-19 & beyond” and “Creating vaccines: Why we… Read More

#Podcasts

#CRISPR #Gene editing #Life sciences #Therapeutics

Horizon Discovery extends gene modulation portfolio

Horizon Discovery, a PerkinElmer company, announced that it is expanding its gene editing and modulation portfolio to include a new family of CRISPR modulation (CRISPRmod) reagents for CRISPR interference (CRISPRi). CRISPRi enables scientists to better understand the biological pathways, processes and pathologies of disease by repressing genes at the transcriptional… Read More

#News

#Cancer #Clinical trial #Life sciences #Novel therapeutics #Oncology

SignalChem collaborates with Merck on advanced non-small cell lung cancer

SignalChem Lifesciences, a clinical-stage company who develop novel targeted therapies for oncology, has announced its collaboration with Merck, through a subsidiary, to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer (NSCLC). AXL,… Read More

#Cancer Research #News

#AstraZeneca #Big pharma #Business #Covid-19 #Life sciences #Pfizer

Why investors have their eye on the pharmaceutical sector

Andrew Aldridge, Partner at  Deepbridge Capital explains why life science sector has shot up the UK investment agenda as vaccinations are rolled out. The past twelve months have showcased the importance of medical developments like never before. Innovation in the life sciences sector has been headline news around the globe and… Read More

#Business & Investment #Covid-19 #News #Opinion

#Cell and gene therapy #Drug delivery #Gene therapy #Life sciences

£18m network of gene therapy hubs to be created in the UK

LifeArc and the Medical Research Council (MRC), with support from the Biotechnology and Biological Sciences Research Council (BBSRC), have announced three major investments totalling £18 million to create a network of gene therapy innovation hubs. The funding will support the creation of three facilities to advance the clinical development of… Read More

#Editor's Choice #News

#Biotechnology #Clinical diagnostics #Life sciences

Bio-Techne certified for its Bristol manufacturing facility

Bio-Techne, a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities, announced that its Bristol site has received ISO 9001:2015 Quality Management Systems certification. Bio-Techne’s Bristol facility produces life science reagents for research use. ISO 9001:2015 is an internationally recognised quality standard intended… Read More

#News

#Biomedical research #Events #Life sciences #Toxicology

2021 Society of Toxicology ToxExpo

LifeNet Health LifeSciences, provider and collaborators in human in vitro biology and drug discovery optimisation, is highlighting innovative human cell and tissue-based research solutions at this year’s ToxExpo. The showcase includes the new, all-human Tri-Culture model, thyrocytes for use in 3D models and genotyped human hepatocytes. It can be found… Read More

#News

#Biotechnology #Life sciences #Pharma #Report #Therapeutics

Report shows growth in advanced therapeutics in Stockholm

A new report from Invest Stockholm on Advanced Therapeutics Manufacturing and Life Science in the Stockholm region showed that the sector has grown by 66% in the past four years. Collaboration between local tech and pharma industries are expected to further enhance Stockholm’s competitiveness and growth in the future. Both… Read More

#Editor's Choice #News #Trending News

#Biopharmaceutical #Bioproduction #Biotechnology #Clinical diagnostics #Life sciences

Advanced Biological Safety Cabinet launched

Thermo Fisher Scientific has launched the Thermo Scientific Herasafe 2025 BSC, for the safe sample handling needs of life science applications. It is a Class II Biological Safety Cabinet (BSC) designed to meet the sample and user protection requirements of bioprocessing, clinical diagnostic and biopharmaceutical laboratories. According to Thermo Fisher… Read More

#News

#Immunology / Virology & Vaccines #Life sciences #mRNA #Pharmaceutical

What the UK Budget means for the pharma sector: industry reaction

By Lu Rahman In his 2021 Budget, UK Chancellor of the Exchequer, Rishi Sunak, announced a range of measures designed to benefit UK science, business and technology. These included tax breaks for firms to designed to ‘unlock’ £20bn worth of business investment; incentives for companies to take on apprentices; allowing… Read More

#Editor's Choice #News #Trending News

#Covid-19 #Immunology / Virology & Vaccines #Life sciences

Despite COVID-19, Swedish life science companies in growth mode

A new survey conducted by SwedenBIO shows that Swedish life science companies are more confident about future growth than they were before COVID-19, with 80% planning for new hires and expansion. The survey shows a major upswing in the industry, following on from similar reports a year ago which demonstrated… Read More

#Covid-19 #News

#Life sciences #Report

Life science report released on shaping the life sciences industry

Global law firm Hogan Lovells has released its fourth annual Life Sciences and Health Care Horizons report, which takes an in-depth look at the opportunities, evolving trends and challenges shaping the future of the life sciences and health care industry. It provides “a high level overview of the potential opportunities,… Read More

#News